Acer Therapeutics Inc (NASDAQ:ACER)

4.33
Delayed Data
As of Jan 17
 0.00 / 0.00%
Today’s Change
1.87
Today|||52-Week Range
28.25
+7.98%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +84.76% increase from the last price of 4.33.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Acer Therapeutics Inc. This rating has held steady since November, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.47
Sales
$0.00
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.62%
 
 
 
 
 
 
Growthannually -14.93%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.